Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. INBIOGEN CO.,Ltd
  6. News
  7. Summary
    A101140   KR7101140002

INBIOGEN CO.,LTD

(A101140)
  Report
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Vidente Co., Ltd. announced that it expects to receive KRW 40 billion in funding from BTONE CO.,Ltd

11/06/2020 EST

Vidente Co., Ltd. (KOSDAQ:A121800) announced a private placement of series 13 unregistered coupon non-guaranteed private convertible bonds for gross proceeds of KRW 30,000,000,000 and series 14 unregistered coupon non-guaranteed private convertible bonds for gross proceeds of KRW 10,000,000,000, for aggregate gross proceeds of KRW 40,000,000,000 on November 6, 2020. The transaction will include participation from Cater Investment Fund for KRW 30,000,000,000 each for the series 13 bonds and returning investor BTONE CO.,Ltd for KRW 10,000,000,000 each for the series 14 bonds. The series 13 and series 14 bonds bear coupon rate of 1% and zero and yield to maturity of 1% per annum, will mature on December 22, 2023. The series 13 bonds are 100% convertible into 4,233,102 common shares and series 14 bonds will be convertible in to 1,411,034 common shares at a conversion price of KRW 7,087 per share. The conversion period of the series 13 and series 14 bonds starts on December 22, 2021 and ends on November 22, 2023. The transaction has been approved by the board of directors of the company. The bonds are subject to prohibition of conversion and partitioning for one year from the date of issue of bonds. The subscription is November 10, 2020 and the payment date is December 22, 2020.


ę S&P Capital IQ 2020
All news about INBIOGEN CO.,LTD
11/24INBIOGEN CO.,Ltd announced that it expects to receive KRW 60.00000234 billion in fundin..
CI
11/23Vidente Co., Ltd. announced that it expects to receive KRW 30.00001347 billion in fundi..
CI
11/18INBIOGEN CO.,Ltd announced that it expects to receive KRW 30.00000262 billion in fundin..
CI
11/18Vidente Co., Ltd. announced that it expects to receive KRW 30.00000966 billion in fundi..
CI
11/15INBIOGEN CO.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended S..
CI
08/31INBIOGEN CO.,Ltd announced that it has received KRW 15 billion in funding
CI
05/31INBIOGEN CO.,Ltd announced that it has received KRW 23.300002 billion in funding from B..
CI
2020Vidente Co., Ltd. announced that it has received KRW 40 billion in funding from INBIOGE..
CI
2020INBIOGEN CO.,Ltd announced that it expects to receive KRW 25.00000128 billion in fundin..
CI
2020BTONE CO.,Ltd announced that it has received KRW 20 billion in funding
CI
More news
Financials
Sales 2020 10 218 M 8,65 M 8,65 M
Net income 2020 -45 078 M -38,2 M -38,2 M
Net cash 2020 74 263 M 62,9 M 62,9 M
P/E ratio 2020 -4,81x
Yield 2020 -
Capitalization 222 B 187 M 188 M
EV / Sales 2019 9,91x
EV / Sales 2020 17,5x
Nbr of Employees 41
Free-Float 56,8%
Chart INBIOGEN CO.,LTD
Duration : Period :
INBIOGEN CO.,Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INBIOGEN CO.,LTD
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Managers and Directors
Sang-Jun Lee Co-Chief Executive Officer & Director
Sang-Woo Kim Co-Chief Executive Officer & Director
In-Seop Oh Independent Director
Kang-Ho Kim Independent Director
Jeong-Hoon Lee Non-Executive Director